Optics11

Based in Amsterdam, Netherlands, and founded in 2011 by Hans Brouwer and Davide Iannuzzi, Optics11 B. V. is a fiber optics life science instrumentation company that leverages its photonics expertise by enabling high throughput screening of the mechanical fingerprints of cells, tissues, and their micro-environment, enabling customers to capture a vast range of insights informing new therapeutic approaches that underpin personalized medicine, and for quality control in biomaterials for regenerative therapies. In January 2026, Optics11 B.

V. raised EUR 25 million in venture debt funding from new investor European Investment Bank. The company’s product line includes a wide range of table-top nanoindenters instruments, including pavone, piuma, and chiaro to measure complex, irregular biomaterials such as single cells, tissues, hydrogels, and coatings and provide various mechanical parameters relevant for mechanical phenotyping, drug development, and tissue engineering. In addition, Optics11 offers an online marketplace that allows users to purchase its nanoindenters instruments.

The company generates revenue through the sale and deployment of fiber‑optic sensing hardware, integrated monitoring systems, and associated software solutions for energy operators, defense organizations, and infrastructure owners. The company plans to use the January 2026 funding to expand its operations, strengthen its financial position, and invest in strategic projects aimed at growth and development.